Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor + Aspirin in mild non-cardioembolic ischemic stroke
NCT04738097Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Aug 2021
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ticagrelor in ischemic stroke, Transient Ischemic Attack (TIA), sponsored by Mazandaran University of Medical Sciences. Started Aug 2021; status: completed.
02
Drugs
ticagrelor
03
Conditions
ischemic strokeTransient Ischemic Attack (TIA)
Beyond the preview
Go deeper on NCT04738097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04738097.